HealthEquity Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

HealthEquity şirketinin toplam hissedar öz sermayesi $2.2B ve toplam borcu $1.1B olup, bu da borç-öz sermaye oranını 51.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $3.5B ve $1.4B dir. HealthEquity 'in FAVÖK'ü $179.2M faiz karşılama oranı 4.6 dur. Şirketin $326.9M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

51.1%

Borç/özkaynak oranı

US$1.10b

Borç

Faiz karşılama oranı	4.6x
Nakit	US$326.89m
Eşitlik	US$2.16b
Toplam yükümlülükler	US$1.36b
Toplam varlıklar	US$3.51b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 2HE 'nin kısa vadeli varlıkları ( $495.6M ) kısa vadeli yükümlülüklerini ( $120.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: 2HE 'un kısa vadeli varlıkları ( $495.6M ) uzun vadeli yükümlülüklerini ( $1.2B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 2HE 'nin net borç/öz sermaye oranı ( 35.9% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 2HE şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 51.1% seviyesine yükseldi.

Borç Kapsamı: 2HE 'nin borcu işletme nakit akışı ( 27.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 2HE 'in borcuna ilişkin faiz ödemeleri EBIT ( 4.6 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

HealthEquity Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

HealthEquity, Inc. Announces CEO Changes, Effective January 6, 2025

HealthEquity, Inc. to Report Q3, 2025 Results on Dec 09, 2024

HealthEquity, Inc Launches HSAnswers

Executive VP & CTO recently sold €853k worth of stock

Second quarter 2025 earnings released: EPS: US$0.41 (vs US$0.12 in 2Q 2024)

HealthEquity, Inc. (NasdaqGS:HQY) announces an Equity Buyback for $300 million worth of its shares.

HealthEquity, Inc. to Report Q2, 2025 Results on Sep 03, 2024

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025

First quarter 2025 earnings released: EPS: US$0.33 (vs US$0.048 in 1Q 2024)

HealthEquity, Inc. to Report Q1, 2025 Results on Jun 03, 2024

HealthEquity, Inc., Annual General Meeting, Jun 27, 2024

Full year 2024 earnings released: EPS: US$0.65 (vs US$0.31 loss in FY 2023)

HealthEquity, Inc. to Report Q4, 2024 Results on Mar 19, 2024

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025

Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.019 loss in 3Q 2023)

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025

HealthEquity, Inc. to Report Q3, 2024 Results on Dec 05, 2023

HealthEquity, Inc. (NasdaqGS:HQY) entered into a definitive agreement to acquire BenefitWallet’s Health Savings Account (HSA) portfolio from Conduent Business Services, LLC for $425 million.

Now 21% undervalued

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024

Second quarter 2024 earnings released: EPS: US$0.12 (vs US$0.13 loss in 2Q 2023)

HealthEquity, Inc. to Report Q2, 2024 Results on Sep 05, 2023

HealthEquity, Inc. Announces the Termination of the Employment of Larry Trittschuh, Executive Vice President and Chief Security Officer

Executive VP & CTO recently sold €607k worth of stock

HealthEquity, Inc. Announces Change of CFO

First quarter 2024 earnings released: EPS: US$0.048 (vs US$0.16 loss in 1Q 2023)

HealthEquity, Inc. Provides Earnings Guidance for the Year Ending January 31, 2024

HealthEquity, Inc. to Report Q1, 2024 Results on Jun 05, 2023

Full year 2023 earnings released: US$0.31 loss per share (vs US$0.53 loss in FY 2022)

Now 22% undervalued after recent price drop

Independent Director recently sold €305k worth of stock

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 and January 31, 2024

Third quarter 2023 earnings released: US$0.019 loss per share (vs US$0.06 loss in 3Q 2022)

HealthEquity, Inc. to Report Q3, 2023 Results on Dec 06, 2022

Independent Director recently sold €312k worth of stock

Independent Director recently sold €1.8m worth of stock

Second quarter 2023 earnings released: US$0.13 loss per share (vs US$0.046 loss in 2Q 2022)

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

Healthequity, Inc. Elects Paul M. Black to Board of Directors and to Audit and Risk Committee and Talent, Compensation and Culture Committee

HealthEquity, Inc. to Report Q2, 2023 Results on Sep 06, 2022

HealthEquity, Inc. Announces Executive Changes

First quarter 2023 earnings released: US$0.16 loss per share (vs US$0.032 loss in 1Q 2022)

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

HealthEquity, Inc. to Report Q1, 2023 Results on Jun 06, 2022

HealthEquity, Inc., Annual General Meeting, Jun 23, 2022

HealthEquity, Inc. Expands Board of Directors

Insufficient new directors

HealthEquity, Inc. to Report Q4, 2022 Results on Mar 22, 2022

HealthEquity, Inc. Provides Revenue Guidance for the Fiscal Year 2023

Independent Director recently bought €949k worth of stock

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2022

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Independent Director recently sold €462k worth of stock

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2022

Second quarter 2022 earnings released: EPS US$0.56 (vs US$0.002 loss in 2Q 2021)

Executive Vice President of Sales William Otten has left the company

Independent Director recently sold €647k worth of stock

Independent Director recently sold €290k worth of stock

Healthequity, Inc. Revises Earnings Guidance for the Fiscal Year Ending January 31, 2022

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2022

First quarter 2022 earnings released: US$0.032 loss per share (vs US$0.026 profit in 1Q 2021)

HealthEquity, Inc. (NasdaqGS:HQY) entered into a Custodial Transfer and Asset Purchase Agreement to acquire Health Savings Account Business of Fifth Third Bancorp from Fifth Third Bank, National Association for $60.8 million.

Full year 2021 earnings released: EPS US$0.12 (vs US$0.59 in FY 2020)

Full year 2021 earnings released: EPS US$0.12 (vs US$0.59 in FY 2020)

HealthEquity, Inc. (NasdaqGS:HQY) acquired Luum from Evan McCordick for $67.2 million.

HealthEquity, Inc. to Report Q4, 2021 Results on Mar 15, 2021

HealthEquity, Inc. has completed a Follow-on Equity Offering in the amount of $401.5 million.

New 90-day high: €64.00

Independent Director recently sold €202k worth of stock

Executive Vice President of Sales recently sold €103k worth of stock

Revenue beats expectations

Third quarter 2021 earnings released: EPS US$0.023

Healthequity, Inc. Appoints Stuart Parker as A Member of the Board

HealthEquity, Inc. to Report Q3, 2021 Results on Dec 07, 2020

New 90-day high: €53.50